Evidence map›Paper›PMID 31111459›Full record

ArticleNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation2019

Enhancing cardiovascular artificial intelligence (AI) research in the Netherlands: CVON-AI consortium.

J W Benjamins, K van Leeuwen, L Hofstra, M Rienstra, Y Appelman, W Nijhof, B Verlaat, I Everts, H M den Ruijter, I Isgum and 5 more

Abstract read
In one paragraph

Article in Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  5. The history of transcatheter aortic valve implantation: The role and contribution of an early believer and adopter, the Netherlands.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2020
    Review
  6. Article
  7. Artificial intelligence for the general cardiologist.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

J W BenjaminsUniversity of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
K van LeeuwenGo Data Driven, Amsterdam, The Netherlands.
L HofstraCardiologie Centra Nederland B.V., Utrecht, The Netherlands.
M RienstraUniversity of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
Y AppelmanDepartment of Cardiology, Amsterdam Universities Medical Centre, location VU Medical Centre, Amsterdam, The Netherlands.
W NijhofSiemens Healthcare Nederland B.V., Den Haag, The Netherlands.
B VerlaatBinx.io B.V., Amsterdam, The Netherlands.
I EvertsGo Data Driven, Amsterdam, The Netherlands.
H M den RuijterDepartment of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
I IsgumDepartment of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
T LeinerDepartment of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
R VliegenthartUniversity of Groningen, University Medical Center Groningen, Department of Radiology, Groningen, The Netherlands.
F W AsselbergsDepartment of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
L E Juarez-OrozcoUniversity of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
P van der HarstUniversity of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands. p.van.der.harst@umcg.nl.

Funding

Hartstichting 2018B017
6 · The paper itself

Abstract

backgroundMachine learning (ML) allows the exploration and progressive improvement of very complex high-dimensional data patterns that can be utilised to optimise specific classification and prediction tasks, outperforming traditional statistical approaches. An enormous acceleration of ready-to-use tools and artificial intelligence (AI) applications, shaped by the emergence, refinement, and application of powerful ML algorithms in several areas of knowledge, is ongoing. Although such progress has begun to permeate the medical sciences and clinical medicine, implementation in cardiovascular medicine and research is still in its infancy.

objectivesTo lay out the theoretical framework, purpose, and structure of a novel AI consortium.

methodsWe have established a new Dutch research consortium, the CVON-AI, supported by the Netherlands Heart Foundation, to catalyse and facilitate the development and utilisation of AI solutions for existing and emerging cardiovascular research initiatives and to raise AI awareness in the cardiovascular research community. CVON-AI will connect to previously established CVON consortia and apply a cloud-based AI platform to supplement their planned traditional data-analysis approach.

resultsA pilot experiment on the CVON-AI cloud was conducted using cardiac magnetic resonance data. It demonstrated the feasibility of the platform and documented excellent correlation between AI-generated ventricular function estimates as compared to expert manual annotations. The resulting AI solution was then integrated in a web application.

conclusionCVON-AI is a new consortium meant to facilitate the implementation and raise awareness of AI in cardiovascular research in the Netherlands. CVON-AI will create an accessible cloud-based platform for cardiovascular researchers, demonstrate the clinical applicability of AI, optimise the analytical methodology of other ongoing CVON consortia, and promote AI awareness through education and training.

Indexed as

Artificial intelligenceCardiovascular diseaseCVON-AI consortiumMachine learning

Identifiers

PMID31111459
PMCPMC6712143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.